Abstract
Treatment of hypertension with diuretics and beta-blockers is often associated with changes in lipids and uric acid levels. The clinical importance of these metabolic changes is still uncertain, but potentially they might counteract the beneficial effect of blood pressure reduction in some patients. As these drugs are widely used to prevent the cardiovascular complications of hypertension, it is imperative that we evaluate the effect of these drug-induced metabolic changes on the atherosclerotic process in humans.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
